These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3955550)

  • 1. Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice.
    Patronas NJ; Cohen JS; Knop RH; Dwyer AJ; Colcher D; Lundy J; Mornex F; Hambright P; Sohn M; Myers CE
    Cancer Treat Rep; 1986 Mar; 70(3):391-5. PubMed ID: 3955550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice.
    Furmanski P; Longley C
    Cancer Res; 1988 Aug; 48(16):4604-10. PubMed ID: 3396012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloporphyrin magnetic resonance contrast agents. Feasibility of tumor-specific magnetic resonance imaging.
    van Zijl PC; Place DA; Cohen JS; Faustino PJ; Lyon RC; Patronas NJ
    Acta Radiol Suppl; 1990; 374():75-9. PubMed ID: 1966973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor enhancement using Mn-metalloporphyrin in mice: magnetic resonance imaging and histopathologic correlation.
    Nasu H; Takehara Y; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I; Sakahara H
    J Magn Reson Imaging; 2004 Aug; 20(2):294-9. PubMed ID: 15269956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI contrast-dose relationship of manganese(III)tetra(4-sulfonatophenyl) porphyrin with human xenograft tumors in nude mice at 2.0 T.
    Place DA; Faustino PJ; Berghmans KK; van Zijl PC; Chesnick AS; Cohen JS
    Magn Reson Imaging; 1992; 10(6):919-28. PubMed ID: 1461089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I
    Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results.
    Mäurer J; Strauss A; Ebert W; Bauer H; Felix R
    Melanoma Res; 2000 Feb; 10(1):40-6. PubMed ID: 10711639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution and stability of metalloporphyrin MRI contrast agents.
    Lyon RC; Faustino PJ; Cohen JS; Katz A; Mornex F; Colcher D; Baglin C; Koenig SH; Hambright P
    Magn Reson Med; 1987 Jan; 4(1):24-33. PubMed ID: 3821476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast enhancement of PC-3 prostate cancer for magnetic resonance imaging: animal studies using tumor-localizing Mn-metalloporphyrin (THF-Mn-Asp).
    Suzuki T; Nakano K; Tomiyoshi K; Sakata I; Endo K; Yamanaka H
    J Urol; 1996 Nov; 156(5):1850-2. PubMed ID: 8863630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
    Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloporphyrins as contrast agents for tumors in magnetic resonance imaging.
    Place DA; Faustino PJ; van Zijl PC; Chesnick A; Cohen JS
    Invest Radiol; 1990 Sep; 25 Suppl 1():S69-70. PubMed ID: 2283262
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical experience with NMR-tomography].
    Friedburg H; Wenz W; Fiebig H
    Rontgenpraxis; 1984 Apr; 37(4):139-45. PubMed ID: 6729609
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mn-TPPS4; a potential MRI contrast agent for localizing the normal aortic wall in rabbits].
    Kim SW; Kozuka T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):192-4. PubMed ID: 2362799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic metastasis of human colon carcinoma: establishment of a nude mouse model and its magnetic resonance imaging].
    Xie Q; Liang BL; Jiang XQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):97-100. PubMed ID: 18227037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
    Kobayashi H; Saga T; Kawamoto S; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Cancer Res; 2001 Jul; 61(13):4966-70. PubMed ID: 11431325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.
    Ogan MD; Revel D; Brasch RC
    Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
    Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
    Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.